Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patients.
Saved in:
| Title: | Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patients. |
|---|---|
| Authors: | Lin MH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan., Ye RH; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan., Jhou HJ; Neurological Institute, Changhua Christian Hospital, Changhua, Taiwan., Chen HY; Department of Family Medicine, Chi Mei Medical Center, Tainan, Taiwan., Kao LT; Graduate Institute of Life Sciences, National Defense Medical University, Taipei, Taiwan.; School of Pharmacy, National Defense Medical University, Taipei, Taiwan.; Department of Pharmacy Practice, Tri-Service General Hospital, Taipei, Taiwan., Hsieh TY; Department of Obstetrics & Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Chen YH; Department of Internal Medicine, Englewood Hospital and Medical Center, Englewood, NJ, USA., Yue-En Sun A; College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., Zhang X; Department of Internal Medicine, NYC Health + Hospitals/Jacobi, Albert Einstein College of Medicine, Bronx, NY, USA., Dai MS; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan., Ho CL; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.; Division of Hematology and Oncology, Medical Department, Taipei Tzu Chi Hospital, Taipei, Taiwan., Chen PH; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan. chenpohuang@hotmail.com., Lee CH; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan. drleechohao@gmail.com. |
| Source: | Diabetology & metabolic syndrome [Diabetol Metab Syndr] 2025 Oct 03; Vol. 17 (1), pp. 377. Date of Electronic Publication: 2025 Oct 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101488958 Publication Model: Electronic Cited Medium: Print ISSN: 1758-5996 (Print) Linking ISSN: 17585996 NLM ISO Abbreviation: Diabetol Metab Syndr Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1758-5996 |
|---|---|
| DOI: | 10.1186/s13098-025-01940-0 |
